Pulsed Dye Laser for Treatment of Basal Cell Carcinoma
Background:. Basal cell carcinoma (BCC) is the most common malignancy worldwide. The incidence of BCC is increasing up to 10% per year worldwide. Surgical excision and Mohs surgery are the gold standard treatment modalities. However, patients may not be candidates for surgery. Pulsed dye laser (PDL)...
Main Authors: | Kelsey L. Baran, DO, Tiffany C. Cheung, DO, George A. Csank, MD, Basil M. Michaels, MD, FACS |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer
2023-03-01
|
Series: | Plastic and Reconstructive Surgery, Global Open |
Online Access: | http://journals.lww.com/prsgo/fulltext/10.1097/GOX.0000000000004850 |
Similar Items
-
Successful treatment of facial telangiectasia from carcinoid syndrome with pulsed dye laser therapy
by: Roy Jiang, MD, PhD, et al.
Published: (2023-10-01) -
Fox-fordyce disease: Pulsed dye laser versus fractional Co2 laser treatment
by: Abdulaziz Alnoshan, MD, et al.
Published: (2023-10-01) -
Treatment of Locally Advanced Basal Cell Carcinomas with Vismodegib
by: Luis Mastronardi, MD, et al.
Published: (2021-10-01) -
Treatment of basal cell cancer in the periorbital area using a pulsed copper vapour laser
by: S. V. Klyuchareva, et al.
Published: (2019-04-01) -
Fractional CO2 laser is as effective as pulsed dye laser for the treatment of hypertrophic scars
by: Mohammad Radmanesh, et al.
Published: (2021-08-01)